Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cescato

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|April 16, 2008
Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivityChristy Rani R Grace, Judit Erchegyi, Manoj Samant, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumoursRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumorsMelpomeni Fani, Andreas Mueller, Maria-Luisa Tamma, et al.
Journal of Medicinal Chemistry|April 16, 2008
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinityJudit Erchegyi, Christy Rani R Grace, Manoj Samant, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targetingMihaela Ginj, Hanwen Zhang, Klaus-Peter Eisenwiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2006
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumorsMihaela Ginj, Hanwen Zhang, Beatrice Waser, et al.
Journal of Medicinal Chemistry|April 9, 2009
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analoguesJudit Erchegyi, Renzo Cescato, Christy Rani R Grace, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|April 16, 2008
Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivityChristy Rani R Grace, Judit Erchegyi, Manoj Samant, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumoursRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumorsMelpomeni Fani, Andreas Mueller, Maria-Luisa Tamma, et al.
Journal of Medicinal Chemistry|April 16, 2008
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinityJudit Erchegyi, Christy Rani R Grace, Manoj Samant, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targetingMihaela Ginj, Hanwen Zhang, Klaus-Peter Eisenwiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2006
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumorsMihaela Ginj, Hanwen Zhang, Beatrice Waser, et al.
Journal of Medicinal Chemistry|April 9, 2009
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analoguesJudit Erchegyi, Renzo Cescato, Christy Rani R Grace, et al.
Pageof 13